Interrogation of gossypol therapy in glioblastoma implementing cell line and patient-derived tumour models

Abstract

Our results indicate that response to a combined gossypol/TMZ treatment is related to inhibition of tumour-associated angiogenesis, invasion and proliferation and warrants further investigation as a novel targeted GBM treatment strategy.